Surrozen Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 41

Employees

  • Stock Symbol
  • SRZN

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $8.41
  • (As of Tuesday Closing)

Surrozen General Information

Description

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Contact Information

Website
www.surrozen.com
Formerly Known As
Consonance
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 171 Oyster Point Boulevard
  • Suite 400
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Vertical(s)
Life Sciences
Corporate Office
  • 171 Oyster Point Boulevard
  • Suite 400
  • South San Francisco, CA 94080
  • United States
+1 (650)

Surrozen Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Surrozen Stock Performance

As of 15-Jul-2025, Surrozen’s stock price is $8.41. Its current market cap is $72.1M with 8.56M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$8.41 $8.61 $5.90 - $18.17 $72.1M 8.56M 13.7K -$24.96

Surrozen Financials Summary

As of 31-Mar-2025, Surrozen has a trailing 12-month revenue of $11.6M.

In Thousands,
USD 		TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 72,951 17,150 (20,313) (54,973)
Revenue 11,638 10,655 0 12,500
EBITDA (81,964) (63,815) (43,471) (34,830)
Net Income (81,704) (63,564) (43,042) (36,004)
Total Assets 114,829 48,467 46,080 89,435
Total Debt 7,968 8,469 3,379 5,602
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Surrozen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Surrozen‘s full profile, request access.

Request a free trial

Surrozen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Surrozen‘s full profile, request access.

Request a free trial

Surrozen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to select
Drug Discovery
South San Francisco, CA
41 As of 2024

Boston, MA
 

Melbourne, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Surrozen Competitors (34)

One of Surrozen’s 34 competitors is Gamida Cell, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gamida Cell Formerly VC-backed Boston, MA
Patrys Formerly VC-backed Melbourne, Australia
Mesoblast Corporation Melbourne, Australia
Sernova Corporation London, Canada
Orgenesis Corporation Germantown, MD
You’re viewing 5 of 34 competitors. Get the full list »

Surrozen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Surrozen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Surrozen‘s full profile, request access.

Request a free trial

Surrozen Acquisitions (1)

Surrozen’s most recent deal was a Merger/Acquisition with Consonance-HFW Acquisition. The deal was made on 11-Aug-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Consonance-HFW Acquisition 11-Aug-2021 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Surrozen’s complete acquisitions history, request access »

Surrozen FAQs

  • When was Surrozen founded?

    Surrozen was founded in 2015.

  • Where is Surrozen headquartered?

    Surrozen is headquartered in South San Francisco, CA.

  • What is the size of Surrozen?

    Surrozen has 41 total employees.

  • What industry is Surrozen in?

    Surrozen’s primary industry is Drug Discovery.

  • Is Surrozen a private or public company?

    Surrozen is a Public company.

  • What is Surrozen’s stock symbol?

    The ticker symbol for Surrozen is SRZN.

  • What is the current stock price of Surrozen?

    As of 15-Jul-2025 the stock price of Surrozen is $8.41.

  • What is the current market cap of Surrozen?

    The current market capitalization of Surrozen is $72.1M.

  • What is Surrozen’s current revenue?

    The trailing twelve month revenue for Surrozen is $11.6M.

  • Who are Surrozen’s competitors?

    Gamida Cell, Patrys, Mesoblast, Sernova, and Orgenesis are some of the 34 competitors of Surrozen.

  • What is Surrozen’s annual earnings per share (EPS)?

    Surrozen’s EPS for 12 months was -$24.96.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »